These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31502646)

  • 61. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
    Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
    Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictive metabolites for incident myocardial infarction: a two-step meta-analysis of individual patient data from six cohorts comprising 7897 individuals from the COnsortium of METabolomics Studies.
    Nogal A; Alkis T; Lee Y; Kifer D; Hu J; Murphy RA; Huang Z; Wang-Sattler R; Kastenmüler G; Linkohr B; Barrios C; Crespo M; Gieger C; Peters A; Price J; Rexrode KM; Yu B; Menni C
    Cardiovasc Res; 2023 Dec; 119(17):2743-2754. PubMed ID: 37706562
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
    Roy C; Tremblay PY; Bienvenu JF; Ayotte P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of the Dynamic Change of Metabolic Health Status on the Incident Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
    Kim JA; Kim DH; Kim SM; Park YG; Kim NH; Baik SH; Choi KM; Han K; Yoo HJ
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):406-414. PubMed ID: 31884741
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.
    Guasch-Ferré M; Hruby A; Toledo E; Clish CB; Martínez-González MA; Salas-Salvadó J; Hu FB
    Diabetes Care; 2016 May; 39(5):833-46. PubMed ID: 27208380
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Short-term NO2 exposure is associated with long-chain fatty acids in prospective cohorts from Augsburg, Germany: results from an analysis of 138 metabolites and three exposures.
    Ward-Caviness CK; Breitner S; Wolf K; Cyrys J; Kastenmüller G; Wang-Sattler R; Schneider A; Peters A
    Int J Epidemiol; 2016 Oct; 45(5):1528-1538. PubMed ID: 27892410
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry.
    Fang H; Zhang AH; Sun H; Yu JB; Wang L; Wang XJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():112-120. PubMed ID: 30743140
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A High Diet Quality Based on Dietary Recommendations Is Not Associated with Lower Incidence of Type 2 Diabetes in the Malmö Diet and Cancer Cohort.
    Mandalazi E; Drake I; Wirfält E; Orho-Melander M; Sonestedt E
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338354
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metabolite biomarkers of type 2 diabetes mellitus and pre-diabetes: a systematic review and meta-analysis.
    Long J; Yang Z; Wang L; Han Y; Peng C; Yan C; Yan D
    BMC Endocr Disord; 2020 Nov; 20(1):174. PubMed ID: 33228610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospective analysis of circulating metabolites and breast cancer in EPIC.
    His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
    BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma Concentration of Caspase-8 Is Associated With Short Sleep Duration and the Risk of Incident Diabetes Mellitus.
    Svensson T; Svensson AK; Kitlinski M; Almgren P; Engström G; Nilsson J; Orho-Melander M; Nilsson PM; Melander O
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1592-1600. PubMed ID: 29409058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive Project.
    Molvin J; Pareek M; Jujic A; Melander O; Råstam L; Lindblad U; Daka B; Leósdóttir M; Nilsson PM; Olsen MH; Magnusson M
    Sci Rep; 2019 Jan; 9(1):272. PubMed ID: 30670722
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
    Mehta A; Liu C; Nayak A; Tahhan AS; Ko YA; Dhindsa DS; Kim JH; Hayek SS; Sperling LS; Mehta PK; Sun YV; Uppal K; Jones DP; Quyyumi AA
    PLoS One; 2020; 15(8):e0237579. PubMed ID: 32810196
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Xenometabolite signatures in the UC Davis type 2 diabetes mellitus rat model revealed using a metabolomics platform enriched with microbe-derived metabolites.
    Mercer KE; Yeruva L; Pack L; Graham JL; Stanhope KL; Chintapalli SV; Wankhade UD; Shankar K; Havel PJ; Adams SH; Piccolo BD
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G157-G169. PubMed ID: 32508155
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes.
    Zeleznik OA; Poole EM; Lindstrom S; Kraft P; Van Hylckama Vlieg A; Lasky-Su JA; Harrington LB; Hagan K; Kim J; Parry BA; Giordano N; Kabrhel C
    J Thromb Haemost; 2018 Mar; 16(3):500-507. PubMed ID: 29285876
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tryptophan and purine metabolites are consistently upregulated in the urinary metabolome of patients diagnosed with gestational diabetes mellitus throughout pregnancy: A longitudinal metabolomics study of Chinese pregnant women part 2.
    Law KP; Han TL; Mao X; Zhang H
    Clin Chim Acta; 2017 May; 468():126-139. PubMed ID: 28238935
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
    van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
    Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.